Selected Publications

Sreekumar A, Blankemeyer E, Sterner CJ, Pan TC, Pant DK, Acolatse S, Turkistani H, Belka GK, Nayak A, Carlin SD, Assenmacher CA, Sellmyer MA, Mankoff DA, Chodosh LA. Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy. Cancer Discov. 2026 Apr 1;16(4):781-799. doi: 10.1158/2159-8290.CD-25-0919. PMID: 4137083.
- Highlighted in In the Spotlight: Tracking the Dormant Cancer Boneprint. Cancer Discov. 2026 Apr 1;16(4):626-628. doi: 10.1158/2159-8290.CD-26-0163. PMID: 41918353.

Au CC*, Azorín DD*, Carrot-Zhang J*, Corsello SM*, Curiel-Garcia A*, Freed-Pastor W*, Grippin AJ*, Nguyen LC*, Pillai R*, Sreekumar A*, Zabransky DJ*. Insights on Future Directions in Cancer Research from the 2026 AACR NextGen Stars. Cancer Discov. 2026 Apr 1;16(4):670-676. doi: 10.1158/2159-8290.CD-26-0284. PMID: 41918358.
*equal contribution

Sreekumar A, Lu M, Choudhury B, Pan TC, Pant DK, Lawrence-Paul MR, Sterner CJ, Belka GK, Toriumi T, Benz BA, Escobar-Aguirre M, Marino FE, Esko JD, Chodosh LA. B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signaling. Cancer Cell. 2024 Jan 8;42(1):52-69.e7. doi: 10.1016/j.ccell.2023.11.008. Epub 2023 Dec 7. PMID: 38065100.

Highlighted in Research Watch, Cancer Discov, https://doi.org/10.1158/2159-8290.CD-RW2023-202 and Spotlight: Sweet dreams: glycosylation controls tumor cell dormancy. Trends Cancer, 2024 Mar;10(3):180-181. doi: 10.1016/j.trecan.2024.01.011. Epub 2024 Feb 3. PMID: 38311543.